Modulation of ERCC1-XPF Heterodimerization Inhibition via Structural Modification of Small Molecule Inhibitor Side-Chains

Inhibition of DNA repair enzymes is an attractive target for increasing the efficacy of DNA damaging chemotherapies. The ERCC1-XPF heterodimer is a key endonuclease in numerous single and double strand break repair processes, and inhibition of the heterodimerization has previously been shown to sens...

Descripción completa

Detalles Bibliográficos
Autores principales: Weilbeer, Claudia, Jay, David, Donnelly, James C., Gentile, Francesco, Karimi-Busheri, Feridoun, Yang, Xiaoyan, Mani, Rajam S., Yu, Yaping, Elmenoufy, Ahmed H., Barakat, Khaled H., Tuszynski, Jack A., Weinfeld, Michael, West, Frederick G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968952/
https://www.ncbi.nlm.nih.gov/pubmed/35372043
http://dx.doi.org/10.3389/fonc.2022.819172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968952/
https://www.ncbi.nlm.nih.gov/pubmed/35372043
http://dx.doi.org/10.3389/fonc.2022.819172

Ejemplares similares